Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation Study of Single Fraction Early Stage Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04040569
Recruitment Status : Recruiting
First Posted : July 31, 2019
Last Update Posted : October 29, 2021
Sponsor:
Information provided by (Responsible Party):
Asal Rahimi, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2024
Estimated Study Completion Date : August 2025